酪氨酸蛋白激酶受体A3抗体
EK4; End3; Eph receptor A3; EPH-like kinase 4; EPH-like tyrosine kinase 1; EphA3; Ephrin receptor EphA3; Ephrin type-A receptor 3; ETK 1; ETK; ETK1; HEK 4; HEK; Hek4; Human embryo kinase; Mek4; MGC109
KIAA1644蛋白抗体
Hypothetical protein LOC85352; K1644_HUMAN; Kiaa1644; MGC125851; MGC125852; Uncharacterized protein KIAA1644.
卵巢癌相关基因1抗体
Candidate tumor suppressor in ovarian cancer 1; Diphthamide biosynthesis protein 1; Diphthamide biosynthesis protein 2 homolog like 1; Diphthamide biosynthesis protein 2 like; Diptheria toxin resistan
磷酸化原癌基因蛋白18抗体
Stathmin 1 (Phospho-Ser38); Stathmin (Phospho Ser38); Stathmin 1 (Phospho S38); Lag; LAP 18; LAP18; Leukemia associated phosphoprotein p18; Metablastin; Oncoprotein 18; OP 18; OP18; p18; p19; Phosphop
蛋白酶激活受体3抗体
Proteinase Activated Receptor 3; coagulation factor II (thrombin) receptor-like 2; Coagulation factor II receptor-like 2; F2RL2; PAR 3; PAR-3; PAR3; PAR3_HUMAN; protease activated receptor3; Proteinas
Anti-PAX5 Polyclonal Antibody
Anti-PAX5 Polyclonal Antibody 应用 WB IHC 稀释比例 WB 1:500-2000. IHC 1:25-100. 交叉反应 Human